Literature DB >> 17309417

Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers.

Beata V Bajorek1, Susan J Ogle, Margaret J Duguid, Gillian M Shenfield, Ines Krass.   

Abstract

OBJECTIVE: To identify the views of health professionals, patients and their carers on strategies to improve the use and management of warfarin in older patients with atrial fibrillation.
DESIGN: Qualitative study based on analysis of group interviews.
SETTING: A major metropolitan teaching hospital, from 1 March to 30 April 2003. PARTICIPANTS: 14 patients (>/= 65 years) with established atrial fibrillation and taking warfarin, three carers, 12 specialists, eight general practitioners, six community pharmacists, nine hospital pharmacists, and 11 nurses volunteered in response to flyers promoting the study.
RESULTS: Suggested strategies to improve warfarin management targeted support services for GPs and patients. Hospital-based clinicians felt that dissemination of trial evidence to GPs to support treatment recommendations is required, and that GPs need to enlist allied health professionals in the management of patients taking warfarin. GPs preferred access to practical advice from expert colleagues on the day-to-day management. Patients requested more information about warfarin therapy, as access to information is inadequate, particularly from primary sources (GPs, community pharmacists). Verbal and written information are equally important, but a single counselling session or supply of a booklet was viewed as inadequate. Participants identified various interventions for all levels of warfarin management; from the collective input, a framework for management strategies was developed.
CONCLUSIONS: Health professionals and patients require more customised information to support warfarin use and management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309417     DOI: 10.5694/j.1326-5377.2007.tb00856.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  14 in total

Review 1.  Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.

Authors:  Ekta Y Pandya; Beata Bajorek
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

2.  Contemporary approaches to managing atrial fibrillation: A survey of Australian general practitioners.

Authors:  Beata Bajorek; Parker Magin; Sarah Hilmer; Ines Krass
Journal:  Australas Med J       Date:  2015-11-30

Review 3.  How well do guidelines incorporate evidence on patient preferences?

Authors:  Christopher A K Y Chong; Ing-je Chen; Gary Naglie; Murray D Krahn
Journal:  J Gen Intern Med       Date:  2009-04-23       Impact factor: 5.128

4.  Comparing Patient and Provider Experiences with Atrial Fibrillation to Highlight Gaps and Opportunities for Improving Care.

Authors:  Bonnie M Vest; Brian M Quigley; Denise F Lillvis; Caroline Horrigan-Maurer; Rebecca S Firth; Anne B Curtis; Jeffrey M Lackner
Journal:  J Gen Intern Med       Date:  2022-01-06       Impact factor: 6.473

Review 5.  A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.

Authors:  Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2011-04

Review 6.  Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making.

Authors:  Yishen Wang; Beata Bajorek
Journal:  Ther Adv Drug Saf       Date:  2014-02

7.  Validation of the Risk Estimator Decision Aid for Atrial Fibrillation (RED-AF) for predicting 30-day adverse events in emergency department patients with atrial fibrillation.

Authors:  Tyler W Barrett; Cathy A Jenkins; Wesley H Self
Journal:  Ann Emerg Med       Date:  2014-09-20       Impact factor: 5.721

8.  Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.

Authors:  Yishen Wang; Beata Bajorek
Journal:  Int J Clin Pharm       Date:  2016-06-10

Review 9.  Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence.

Authors:  Caleb Ferguson; Sally C Inglis; Phillip J Newton; Sandy Middleton; Peter S Macdonald; Patricia M Davidson
Journal:  Vasc Health Risk Manag       Date:  2013-01-16

10.  Evidence-based study on antithrombotic therapy in patients at risk of a stroke with paroxysmal atrial fibrillation.

Authors:  Xinjun Chen; Ronghua Wan; Wenlong Jiang; Hua Zhang; Ruolong Zhen; Quanzhong Ying; Weizhang Li; Huidong Qian; Feng Wei; Zhuowen Xu; Jianjin Tang; Handong Lei; Yi Zhou
Journal:  Exp Ther Med       Date:  2013-06-05       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.